Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)||
||Other / Industry||
||45||All||60 Years and older (Adult, Senior)||NCT00890929||IRB-15611
|April 2009||June 2011||June 2012||April 30, 2009||October 20, 2014||October 20, 2014||